Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Classics in Chemical Neuroscience: Aripiprazole.

Casey AB, Canal CE.

ACS Chem Neurosci. 2017 Jun 21;8(6):1135-1146. doi: 10.1021/acschemneuro.7b00087. Epub 2017 Apr 13.

2.

Distinct cortical and striatal actions of a β-arrestin-biased dopamine D2 receptor ligand reveal unique antipsychotic-like properties.

Urs NM, Gee SM, Pack TF, McCorvy JD, Evron T, Snyder JC, Yang X, Rodriguiz RM, Borrelli E, Wetsel WC, Jin J, Roth BL, O'Donnell P, Caron MG.

Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8178-E8186. Epub 2016 Dec 1.

3.

The effect of second-generation antipsychotics on hippocampal volume in first episode of psychosis: longitudinal study.

Bodnar M, Malla AK, Makowski C, Chakravarty MM, Joober R, Lepage M.

BJPsych Open. 2016 Mar 9;2(2):139-146. eCollection 2016 Mar.

4.

An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.

Murphy A, Dursun S, McKie S, Elliott R, Deakin JF.

Psychopharmacology (Berl). 2016 Apr;233(8):1415-26. doi: 10.1007/s00213-016-4234-9. Epub 2016 Feb 22.

5.

Aripiprazole: from pharmacological profile to clinical use.

Di Sciascio G, Riva MA.

Neuropsychiatr Dis Treat. 2015 Oct 13;11:2635-47. doi: 10.2147/NDT.S88117. eCollection 2015. Review.

6.

Effects of Add-on Ramelteon on Cognitive Impairment in Patients with Schizophrenia: An Open-label Pilot Trial.

Shirayama Y, Takahashi M, Suzuki M, Tsuruoka Y, Sato K.

Clin Psychopharmacol Neurosci. 2014 Dec;12(3):215-7. doi: 10.9758/cpn.2014.12.3.215. Epub 2014 Dec 26.

7.

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone.

Hori H, Yamada K, Kamada D, Shibata Y, Katsuki A, Yoshimura R, Nakamura J.

Neuropsychiatr Dis Treat. 2014 Mar 26;10:527-33. doi: 10.2147/NDT.S59861. eCollection 2014.

8.
9.

Effect of aripiprazole on mismatch negativity (MMN) in schizophrenia.

Zhou Z, Zhu H, Chen L.

PLoS One. 2013;8(1):e52186. doi: 10.1371/journal.pone.0052186. Epub 2013 Jan 7.

10.

Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan.

Ye W, Ascher-Svanum H, Tanji Y, Flynn JA, Takahashi M.

Patient Prefer Adherence. 2011;5:611-7. doi: 10.2147/PPA.S26002. Epub 2011 Dec 14.

11.

Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice.

Picada JN, Dos Santos Bde J, Celso F, Monteiro JD, Da Rosa KM, Camacho LR, Vieira LR, Freitas TM, Da Silva TG, Pontes VM, Pereira P.

Acta Pharmacol Sin. 2011 Oct;32(10):1225-32. doi: 10.1038/aps.2011.77. Epub 2011 Aug 15.

12.

Antipsychotic treatments for the elderly: efficacy and safety of aripiprazole.

Kohen I, Lester PE, Lam S.

Neuropsychiatr Dis Treat. 2010 Mar 24;6:47-58.

13.

Olanzapine versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Duggan L, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2. Review.

14.

Aripiprazole versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schmid F, Hunger H, Schwarz S, El-Sayeh HG, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006569. doi: 10.1002/14651858.CD006569.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;2:CD006569.

15.

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

Furiak NM, Ascher-Svanum H, Klein RW, Smolen LJ, Lawson AH, Conley RR, Culler SD.

Cost Eff Resour Alloc. 2009 Apr 7;7:4. doi: 10.1186/1478-7547-7-4.

16.

Cognitive-enhancing effects of aripiprazole: a case report.

Mucci A, Piegari G, Galderisi S.

Clin Pract Epidemiol Ment Health. 2008 Oct 29;4:24. doi: 10.1186/1745-0179-4-24.

17.

Neurocognitive deficits in the (putative) prodrome and first episode of psychosis.

Eastvold AD, Heaton RK, Cadenhead KS.

Schizophr Res. 2007 Jul;93(1-3):266-77. Epub 2007 Apr 30.

Supplemental Content

Support Center